Advertisement
| tamoxifen alternatives 2022: Probably Someday Cancer Kim Horner, 2019-02-15 After learning that she inherited a BRCA2 genetic mutation that put her at high risk for breast and ovarian cancer, Kim Horner’s doctors urged her to consider having a double mastectomy. But how do you decide whether to have a surgery to remove your breasts to reduce your risk for a disease you don’t have and may never get? Horner shares her struggle to answer that question in Probably Someday Cancer. The mother of a one-year-old boy, she wanted to do whatever would give her the best odds of being around for her son and protect her from breast cancer, which killed her grandmother and great-grandmother in their 40s. Which would give her the best chance at a long healthy life: a double mastectomy or frequent screenings to try to catch any cancer early? The answers weren’t that simple. Based on extensive research, interviews, and personal experience, Horner writes about how and why she ultimately opted for a double mastectomy—the same decision actress Angelina Jolie made for a similar genetic mutation—and the surprising diagnosis that followed. The book explores difficult truths that get overshadowed by upbeat messages about early detection and survivorship—the fact that screenings can miss cancers and that even early-stage breast cancers can spread and become fatal. Probably Someday Cancer is about the author’s efforts to push past her fear and anxiety. This book can help anyone facing hereditary risk of breast and ovarian cancer feel less alone and make informed decisions to protect their health and end the devastation that hereditary cancer has caused for generations in so many families. |
| tamoxifen alternatives 2022: The Breast K. I. Bland, Edward M. Copeland, 2009 Offering the most comprehensive, up-to-date information on the diagnosis and management of, and rehabilitation following, surgery for benign and malignant diseases of the breast, this surgical reference is now in a new edition available in both print and online for easy, convenient access to the absolute latest advances. |
| tamoxifen alternatives 2022: The APRN and PA’s Complete Guide to Prescribing Drug Therapy 2022 Mari J. Wirfs, PhD, MN, APRN, ANP-BC, FNP-BC, CNE, 2021-07-06 Includes 25 new diagnoses and digital updates as needed! The only prescribing guide conveniently organized by clinical diagnoses for adult and pediatric patients, this concise resource is an unrivaled reference tool for advanced health care providers (AHCPs) and students in all clinical practice settings who need guidance on prescribing drugs for patients with acute, episodic, and chronic health problems. Newly updated for 2022 with the most recent drug information and clinical guidance, this revised edition contains 25 new diagnoses including 15 additional cancer diagnoses and the novel Coronavirus (COVID-19). The APRN and PA's Complete Guide to Prescribing Drug Therapy 2022 intersperses clinically useful information throughout, such as monitored laboratory values, patient teaching points, and safety information. Section I alphabetically presents pharmacotherapy regimens for more than 600 clinical diagnoses. Each diagnosis contains drug choices alphabetically by generic name, FDA pregnancy category, OTC availability, generic availability, adult and pediatric dosing regimens, brand/trade names, available dose forms, and additive information. Section II uses a convenient table format to convey pediatric and adult immunization schedules, contraceptives, pediatric dosing tables for liquid anti infectives, and much more. An alphabetical cross reference index of drugs by generic and brand/trade names, with FDA pregnancy category and controlled drug schedule, facilitates quick identification of drugs by alternate names and relative safety during pregnancy. Key Features: Uniquely organized by clinical diagnosis! Addresses drug treatment options for over 600 specific diagnoses Guides the AHCP through drug classes, categories, and brand/trade names for primary care health issues Contains over 30 Appendices with quick access to drugs by category (e.g., antineoplastics, anticonvulsants), child and adult immunization schedules, contraceptives by form, glucocorticosteroids by potency, and much more! Index provides cross referencing of drugs by generic and brand/trade names Includes eBook and regular updates with purchase of print guide |
| tamoxifen alternatives 2022: Adjuvant Therapy for Breast Cancer Monica Castiglione, Martine J. Piccart, 2009-07-11 Adjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for breast conserving procedures or reducing risk of occurrence. Although there has been much progress towards a cure, including the introduction of new targeted therapies, metastasizing cancer remains highly incurable. |
| tamoxifen alternatives 2022: A Theranostic and Precision Medicine Approach for Female-Specific Cancers Rama Rao Malla, Ganji Purnachandra Nagaraju, 2020-11-06 A Theranostic and Precision Medicine Approach for Female-Specific Cancers provides information regarding ongoing research and clinical data surrounding female specific cancers (breast, cervical, ovarian and endometrial cancers). The book encompasses detailed descriptions about diagnostics and therapeutic options for easy understanding, focusing on the subject matter with a broader range of treatment options. In addition, it explores new theranostics, i.e., diagnostic, therapeutic and precision medicine strategies currently being developed for FSCs. This book is a valuable resource for cancer researchers, clinicians, graduate students and other members of biomedical field who need to understand the most recent and promising approaches to manage FSCs. - Explores new diagnostic biomarkers surrounding the early detection and prognosis of FSCs - Examines new genetic and molecularly targeted approaches for the treatment of these aggressive diseases - Discusses new theranostic approaches that combine diagnosis and treatment through the use of nanotechnology in FSCs - Addresses how these various advances can be integrated into a precision and personalized medicine approach that can eventually enhance patient care |
| tamoxifen alternatives 2022: Handbook of Drug Administration via Enteral Feeding Tubes, 3rd edition Rebecca White, Vicky Bradnam, 2015-03-11 With over 400 drug monographs, this book covers the technical, practical and legal aspects that you should consider before prescribing or administering drugs via enteral feeding tubes. |
| tamoxifen alternatives 2022: Clinical Reproductive Medicine and Surgery E-Book Tommaso Falcone, William Hurd, 2007-04-26 Clinical Reproductive Medicine and Surgery is the new, definitive resource in reproductive medicine. This unique text offers detailed discussion on both the medical and surgical management of reproductive disorders, as well as coverage of associated imaging modalities. Included are chapters on Reproductive Genetics, Management of Endometriosis (including interventional radiology), Ultrasonography and Sonohysterography, Preservation of Fertility, and Recurrent Pregnancy Loss. A resource every practitioner interested in Reproductive Endocrinology and Infertility needs! Offers detailed discussion of medical and surgical management of reproductive disorders ... No other text offers coverage of both medical and surgical management in one resource. Covers gynecologic disorders that impact fertility--an important aspect of identifying fertility issues, not included in major competition Section on basic reproductive biology ... Not overly detailed -- Written for a clinician to understand how to practice reproductive medicine Section on reproductive imaging ... Unique to this text - includes US and MRI of the reproductive organs Algorithm in each chapter ... 4-color throughout ... Demonstrates the appropriate clinical investigation and management ... Offers attractive layout and best views of surgical procedures |
| tamoxifen alternatives 2022: Basic Radiation Oncology Murat Beyzadeoglu, Gokhan Ozyigit, Cüneyt Ebruli, 2010-07-20 This practical, up-to-date, bedside-oriented radiation oncology book encompasses the essential aspects of the subject with coverage on radiation physics, radiobiology, and clinical radiation oncology. The first two sections examine concepts that are crucial in radiation physics and radiobiology. The third section describes radiation treatment regimens appropriate for the main cancer sites and tumor types. |
| tamoxifen alternatives 2022: Medicinal Chemistry of Anticancer Drugs Carmen Avendano, J. Carlos Menendez, 2015-04-28 Medicinal Chemistry of Anticancer Drugs, Second Edition, provides an updated treatment from the point of view of medicinal chemistry and drug design, focusing on the mechanism of action of antitumor drugs from the molecular level, and on the relationship between chemical structure and chemical and biochemical reactivity of antitumor agents. Antitumor chemotherapy is a very active field of research, and a huge amount of information on the topic is generated every year. Cytotoxic chemotherapy is gradually being supplemented by a new generation of drugs that recognize specific targets on the surface or inside cancer cells, and resistance to antitumor drugs continues to be investigated. While these therapies are in their infancy, they hold promise of more effective therapies with fewer side effects. Although many books are available that deal with clinical aspects of cancer chemotherapy, this book provides a sorely needed update from the point of view of medicinal chemistry and drug design. |
| tamoxifen alternatives 2022: Alternative Methods in Neurotoxicology , 2023-06-08 Alternative Methods in Neurotoxicology, Volume Nine, the latest release in this series, provides an overview of important in vitro and non-vertebrate animal models available to study the neurotoxicity of a range of toxicants of occupational and environmental relevance. Chapters in this new release include Evaluation of mitochondrial function in neurotoxicology using alternative models, Planarians as a model to study neurotoxic agents, Role of Drosophila melanogaster in neurotoxicology studies: Responses to different harmful substances, Neurotoxicology of metals and metallic nanoparticles in Caenorhabditis elegans, Neurotoxicology of environmental toxicants using Caenorhabditis elegans as a model, Nauphoeta cinerea as an emerging model in neurotoxicology, and more. Other chapters cover Human Neural Stem Cells in Developmental Neurotoxicology: Current Scenario and Future Prospects, Use of Drosophila melanogaster for advances in developmental neurotoxicology studies, 3D neurospheres and neurotoxicity of organophosphorus and TCE, Genetic factors in methylmercury-induced neurotoxicity: what we have learned from Caenorhabditis elegans models, and more. - Give an up-to-date about the utilization of popular invertebrates (Drosophila melanogaster and Caenorhabditis elegans) in neurotoxicology - Brings concise information on emerging invertebrate models in neurotoxicology (from basic to environmental approaches) - Presents updates on the in vitro exploitation of human stem cell in developmental neurotoxicology |
| tamoxifen alternatives 2022: Cutaneous Wound Healing Vincent Falanga, 2001-08-23 Gene therapy, bioengineered skin, and other methods in advanced biology are revolutionizing the treatment of wounds. Written by experts in research and clinical practice, Cutaneous Wound Healing examines the current knowledge and emerging treatment methods. This volume explains the normal molecular and cellular functions that occur when a wound heals, as well as dysfunctional events, such as a chronic wound or an ulcer. Such dysfunctions signal an imbalance in the body, explained here along with possible treatments. The book's mini-atlas is an indispensable reference tool. Dermatologists, plastic surgeons, and general practitioners can benefit from this text. |
| tamoxifen alternatives 2022: Cancer Chemotherapy and Biotherapy Bruce A. Chabner, Dan L. Longo, 2011-12-07 Updated to include the newest drugs and those currently in development, this Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all drugs and biological agents—their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. The authors explain the rationale for use of drugs in specific schedules and combinations and offer guidelines for dose adjustment in particular situations. This edition's introduction includes timely information on general strategies for drug usage, the science of drug discovery and development, economic and regulatory aspects of cancer drug development, and principles of pharmacokinetics. Eight new chapters have been added and more than twenty have been significantly revised. A companion website includes the fully searchable text and an image bank. |
| tamoxifen alternatives 2022: DNA Adducts International Agency for Research on Cancer, 1994 This is the first and only handbook to provide a comprehensive review of the critical intermediates in the first step of the process of carcinogenesis. This volume reviews current knowledge of DNA adducts formed by a wide range of classes of chemical compound, including the metabolism of chemicals, mechanisms of adduction, preparation and properties of standard compounds, adduct formation in vitro, measurements of adducts in humans, and biological significance. Additional chapters review our understanding of specific types of gene damage and mutagenecity and their reaction to cancer. This volume will provide invaluable, up-to-date facts for all researchers in mechanism of carcinogenesis, toxicology, and molecular epidemiology. |
| tamoxifen alternatives 2022: Drug-induced Ocular Side Effects and Drug Interactions Frederick T. Fraunfelder, 1982 |
| tamoxifen alternatives 2022: Nursing2022 Drug Handbook Lippincott Williams & Wilkins, 2021-03-04 THE #1 Drug Guide for nurses & other clinicians...always dependable, always up to date! Look for these outstanding features: Completely updated nursing-focused drug monographs featuring 3,500 generic, brand-name, and combination drugs in an easy A-to-Z format NEW 32 brand-new FDA-approved drugs in this edition, including the COVID-19 drug remdesivir—tabbed and conveniently grouped in a handy “NEW DRUGS” section for easy retrieval NEW Thousands of clinical updates—new dosages and indications, Black Box warnings, genetic-related information, adverse reactions, nursing considerations, clinical alerts, and patient teaching information Special focus on U.S. and Canadian drug safety issues and concerns Photoguide insert with images of 439 commonly prescribed tablets and capsules |
| tamoxifen alternatives 2022: Essentials of Breast Surgery: A Volume in the Surgical Foundations Series E-Book Michael S. Sabel, 2009-04-23 This new volume in the Surgical Foundations series delivers need-to-know, current information in breast surgery in an exceptionally economical and user-friendly format. Coverage encompasses everything from anatomy and physiology, evaluation of breast symptoms...to discussions of breast cancer risk and management of breast cancer, equipping you to face any challenge with confidence. Whether reviewing key material in preparation for a procedure or studying for the boards, this is an invaluable resource in training and practice. Presents coverage that encompasses anatomy and physiology, evaluation of breast symptoms, breast cancer risk, and management of breast cancer to equip you to face any challenge with confidence. Addresses hot topics including gynecomastia, neoadjuvant therapy, management of ductal carcinoma in situ and Paget’s disease, risk assessment and genetic testing, breast MRI, partial breast irradiation, microarray analysis, and targeted therapies...providing you with a current perspective on this fast changing field. Begins each chapter with a bulleted list of key points, and presents crucial facts in boxes, to help facilitate review. Features abundant illustrations, photographs, and tables that clarify complex concepts. Follows a concise, logical, and consistent organization that makes the material easy to review. |
| tamoxifen alternatives 2022: Cancer Chemotherapy in Clinical Practice Terry J. Priestman, 2007-12-11 This excellent new book summarizes the whole range of systemic cancer therapies, explaining their mode of action and potential side-effects, as well as their clinical applications. It is divided into three sections. The first tackles the theoretical basis of cancer chemotherapy: following an historical introduction, the different treatment modalities are explained in the context of basic tumor biology. The text then moves on to the subject’s practical aspects and covers dosing and drug delivery together with an extensive discussion of possible side-effects. Finally, Priestman looks at chemotherapy in the management of cancers. The book has a consistency of style which makes a wealth of complex information both readily accessible and easily understandable. |
| tamoxifen alternatives 2022: Cancer Chemotherapy in Clinical Practice Terrence Priestman, 2007-11-24 This excellent new book summarizes the whole range of systemic cancer therapies, explaining their mode of action and potential side-effects, as well as their clinical applications. It is divided into three sections. The first tackles the theoretical basis of cancer chemotherapy: following an historical introduction, the different treatment modalities are explained in the context of basic tumor biology. The text then moves on to the subject’s practical aspects and covers dosing and drug delivery together with an extensive discussion of possible side-effects. Finally, Priestman looks at chemotherapy in the management of cancers. The book has a consistency of style which makes a wealth of complex information both readily accessible and easily understandable. |
| tamoxifen alternatives 2022: Talking to My Tatas Dana Brantley-Sieders, 2022-02-15 Talking To My Tatas gives breast cancer patients and survivors easy access to the latest science from breast cancer researcher and survivor Dana Brantley-Sieders. From surgery, tumor genomic testing, and cutting-edge therapies to mental health, sexual health, and avoiding pseudoscience scams, she delivers the goods with a side of humor and hope. |
| tamoxifen alternatives 2022: The Pituitary Shlomo Melmed, 2010-12-09 The pituitary, albeit a small gland, is known as the master gland of the endocrine system and contributes to a wide spectrum of disorders, diseases, and syndromes. Since the publication of the second edition of The Pituitary, in 2002, there have been major advances in the molecular biology research of pituitary hormone production and action and there is now a better understanding of the pathogenesis of pituitary tumors and clinical syndromes resulting in perturbation of pituitary function. There have also been major advances in the clinical management of pituitary disorders. Medical researchers and practitioners now better understand the morbidity and mortality associated with pituitary hormone hyposecretion and hypersecretion. Newly developed drugs, and improved methods of delivering established drugs, are allowing better medical management of acromegaly and prolactinoma. These developments have improved the worldwide consensus around the definition of a cure for pituitary disease, especially hormone hypersecretion, and hence will improve the success or lack of success of various forms of therapy. It is therefore time for a new edition of The Pituitary. The third edition will continue to be divided into sections that summarize normal hypothalamic-pituitary development and function, hypothalamic-pituitary failure, and pituitary tumors; additional sections will describe pituitary disease in systemic disorders and diagnostic procedures, including imaging, assessment of the eyes, and biochemical testing. The first chapter will be completely new – placing a much greater emphasis on physiology and pathogenesis. Two new chapters will be added on the Radiation and Non-surgical Management of the Pituitary and Other Pituitary Lesions. Other chapters will be completely updated and many new author teams will be invited. The second edition published in 2002 and there have been incredible changes in both the research and clinical aspects of the pituitary over the past 8 years – from new advances in growth hormones to pituitary tumor therapy. - Presents a comprehensive, translational source of information about the pituitary in one reference work - Pituitary experts (from all areas of research and practice) take readers from the bench research (cellular and molecular mechanism), through genomic and proteomic analysis, all the way to clinical analysis (histopathology and imaging) and new therapeutic approaches - Clear presentation by endocrine researchers of the cellular and molecular mechanisms underlying pituitary hormones and growth factors as well as new techniques used in detecting lesions (within the organ) and other systemic disorders - Clear presentation by endocrinologists and neuroendocrine surgeons of how imaging, assessment of the eyes, and biochemical testing can lead to new therapeutic approaches |
| tamoxifen alternatives 2022: 40th Annual Meeting of the American Society of Clinical Oncology American Society of Clinical Oncology. Annual Meeting, American Society of Clinical Oncology, 2004 |
| tamoxifen alternatives 2022: Treatment of the Postmenopausal Woman Rogerio A. Lobo, 2007-06-05 For anyone who treats postmenopausal women, this latest edition of Rogerio Lobo's classic work combines the best from two well-known references: Menopause, and the second edition of Treatment of the Postmenopausal Woman. By adding significant discussions of the basic science behind menopause, it is possible to objectively assess the clinical value and limitations of current approaches to treatment and provide a basis and rationale for strategies that will result in better individualized and specialized care. Not only does the third edition discuss diagnosis and treatment of menopause but it covers biological, anatomical, physiological, pathobiological, and pharmacological aspects as well bringing together, in one source, all of the information needed to understand and treat postmenopausal conditions. Over 50% new material representing the vast amount of information available since the Women's Health Initiative (WHI) clinical trials were completed making this the most up-to-date reference on postmenopausal women Includes several new sections on comparisons between clinical trials and observational data, urology, and pelvic support Each section is preceded by a preface to put the area into context with many chapters having suggested treatment regimens |
| tamoxifen alternatives 2022: Cancer Chemoprevention Raymond C. Bergan, 2012-10-24 This volume offers a broad overview of topics related to cancer chemoprevention. It provides a review of topics ranging from basic research arenas to clinical trial design, implementation, and interpretation. It covers all key areas necessary for understanding the field of cancer chemoprevention for the interested reader, for individuals wishing to enter this area of investigation, and for individuals seeking guidance in particular areas of research, relating to agent identification, basic science investigations and clinical trials. The genesis of this book is based on the fact that cancer chemoprevention is a relatively new and rapidly evolving field spanning a wide array of disciplines, and forces researchers to address difficult and complex questions whose answers are not readily available. Cancer Chemoprevention provides a ready resource whose importance and intent lie in its ability to gather and solidify disparate data to explicitly outline areas of difficulty and to highlight future areas of important development. It provides broad outlines for current, ongoing and future directions in this area with various target organ sites, written by experts in their respective fields, whose primary research focuses upon that individual field. |
| tamoxifen alternatives 2022: Collins-Bride & Saxe's Clinical Guidelines for Advanced Practice Nursing Yoonmee Joo, Jim V. Gatewood, Mary Anne Israel, Kelly Wong McGrath, 2024 Collins-Bride & Saxe's Clinical Guidelines for Advanced Practice Nursing, Fourth Edition is an accessible and practical reference designed to help nurses and students with daily clinical decision making. Written in collaboration with certified nurse midwives, clinical nurse specialists, nurse practitioners, nutritionists, pharmacists, and physicians, it fosters a team approach to health care. Divided into four areas-Pediatrics, Gynecology, Obstetrics, and, Adult General Medicine-and following a lifespan approach, it utilizes the S-O-A-P (Subjective-Objective-Assessment-Plan) format. Additionally, the authors explore complex chronic disease management, health promotion across the lifespan, and professional and legal issues such as reimbursement, billing, and the legal scope of practice. The Fourth Edition has a keen focus on gerontology to accommodate the AGNP specialty and to better assist the student or clinician in caring for the aging population. The authors follow the across the life span approach and focus on common complete disorders. Certain chapters have been revised and new chapters have been added which include:Health Maintenance for Older Adults; Frailty; Common Gerontology Syndromes; Cancer Survivorship; Lipid Disorders; Acne (pediatrics section) |
| tamoxifen alternatives 2022: Management of Benign and Malignant Breast Disease, An Issue of Obstetrics and Gynecology Clinics , E-Book Patrice M Weiss, Jessica F. Partin, 2022-02-24 In this issue of Obstetrics and Gynecology Clinics, guest editors Patrice Weiss and Jessica F. Partin bring their considerable expertise to the topic of Management of Benign and Malignant Breast Disease. - Provides in-depth reviews on the latest in Management of Benign and Malignant Breast Disease. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews. |
| tamoxifen alternatives 2022: Aquaporin Regulation Gerald Litwack, 2020-02-13 Aquaporin Regulation, Volume 112, the latest release in the Vitamins and Hormones series, highlights new advances in the field, with this new volume presenting interesting chapters highlighting Perspectives on the evolution of aquaporin superfamily, Structure and dynamics of aquaporin-1, Selectivity and Transport in Aquaporins from Molecular Simulation Studies, Aquaporin regulation in metabolic organs, Phosphorylation of human AQP2 and its role in trafficking, Regulation of Aquaporin-2 by RNA Interference, Aquaporin Regulation: Lessons from Secretory Vesicles, CFTR Regulation of Aquaporin-mediated Water Transport, Glucocorticoid Gene Regulation of Aquaporin-7, and much more. |
| tamoxifen alternatives 2022: The Chemotherapy Source Book Michael Clinton Perry, 2008 The Chemotherapy Source Book, Fourth Edition pulls together all the current information on the chemotherapeutic management of cancer patients, including choice of chemotherapeutic agents, use of combinations, and toxicity of individual drugs. Organized by disease site, the book brings together pharmacologic and patient management information in one source that clinicians can consult for any question encountered in the delivery of chemotherapy. This updated Fourth Edition includes new drugs as well as new indications for older drugs. Content has been streamlined to provide essential information more quickly for the busy practitioner. Plus, this edition is softcover for greater portability and convenience. |
| tamoxifen alternatives 2022: Oestrogen, the Killer in Our Midst Chris Woollams, 2006-01-01 |
| tamoxifen alternatives 2022: Medical Tourism Lydia Gan, 2025-04-03 Medical tourism, a complex interplay of healthcare, economics, and culture, offers both opportunities and challenges for patients, providers, and nations alike. Who seeks medical services abroad, and why? Which procedures are most commonly performed, and which countries are hotspots for medical tourism? What role do intermediary healthcare facilitators play? This book offers an accessible introduction to this multifaceted topic, answering all of these questions and more. The book also explores a variety of issues related to medical tourism, including patients' concerns about quality of care and safety and regulatory gray areas that can arise when medical care crosses national boundaries. A collection of five engaging case studies help bring the subject to life, illustrating concepts and issues discussed in the text. A glossary and annotated directory of resources round out the volume. |
| tamoxifen alternatives 2022: Diseases of the Chest, Breast, Heart and Vessels 2019-2022 Gustav K von Schulthess, Rahel A Kubik-Huch, Juerg Hodler, 2020-10-08 This open access book focuses on diagnostic and interventional imaging of the chest, breast, heart, and vessels. It consists of a remarkable collection of contributions authored by internationally respected experts, featuring the most recent diagnostic developments and technological advances with a highly didactical approach. The chapters are disease-oriented and cover all the relevant imaging modalities, including standard radiography, CT, nuclear medicine with PET, ultrasound and magnetic resonance imaging, as well as imaging-guided interventions. As such, it presents a comprehensive review of current knowledge on imaging of the heart and chest, as well as thoracic interventions and a selection of hot topics. The book is intended for radiologists, however, it is also of interest to clinicians in oncology, cardiology, and pulmonology. This work was published by Saint Philip Street Press pursuant to a Creative Commons license permitting commercial use. All rights not granted by the work's license are retained by the author or authors. |
| tamoxifen alternatives 2022: Breast Cancer and Gynecological Cancer Rehabilitation Adrian Cristian, 2020-09-15 Breast Cancer and Gynecological Cancer Rehabilitation, edited by Adrian Cristian, MD, MHCM, provides today's clinicians with a concise, accessible resource covering the holistic rehabilitation of breast cancer patients. Beginning with a review of epidemiology, genetics, and pathophysiology of breast cancer, it then covers clinical assessment and treatment options before providing comprehensive coverage of rehabilitation. Containing practical information, best practices, and the latest advances and research, this book is a valuable reference for physical medicine and rehabilitation physicians and residents, as well as occupational and physical therapists. - Provides a clear understanding of the current medical, surgical, and radiation treatments for breast cancer. - Covers the whole spectrum of breast cancer rehabilitation, including the role of physical and occupational therapy, treatment of anxiety and depression, pain syndromes, integrative care, nutritional rehabilitation, palliative care, and more. - Offers a timely and convenient resource written by leading experts in breast cancer and rehabilitation. |
| tamoxifen alternatives 2022: Cancer of the Female Reproductive Organs National Cancer Institute (U.S.), 1959 |
| tamoxifen alternatives 2022: Preoperative (Neoadjuvant) Chemotherapy Joseph Ragaz, Pierre R. Band, James H. Goldie, 2012-03-14 Despite recent advances in adjuvant therapies of cancer, the regi mens of postoperative adjuvant chemotherapy treatment which are presently available fail to cure the majority of cancer patients. Pre operative (neoadjuvant) chemotherapy represents a new approach in drug scheduling, based on sound theoretical, pharmacokinetic, and experimental principles. The preoperative timing of chemotherapy before definitive sur gery is not a minor change in the therapy of cancer. To be successful, large numbers of practitioners and their patients must participate. Substantial alterations of many aspects of the present management of cancer will have to follow. Therefore, before such therapy can be fully and routinely implemented, results of the novel treatment and its rationale have to be carefully evaluated. In preoperative treatment, other features will likely gain impor tance. For the first time, clinicians have a chance to follow the in vivo response of the tumor exposed to preoperative chemotherapy. The subsequent histological assessment of the tumor sample may likely become an important prognostic guide, permitting more re fined individual approaches to the planning of postoperative adju vant treatment. The value of such a treatment strategy can already be appreciated in the clinical setting, as seen from the therapy of osteosarcoma. Furthermore, preoperative chemotherapy might render previously inoperable tumors operable and hence resectable with a curative intention. The preoperative reduction of tumor bulk may also effectively decrease the need for more radical operations, permitting a more uniform adoption of conservative surgery. |
| tamoxifen alternatives 2022: Encyclopedia of Dietary Supplements Paul M. Coates, Joseph M. Betz, Marc R. Blackman, Gordon M. Cragg, Mark Levine, Joel Moss, Jeffrey D. White, 2010-06-25 Encyclopedia of Dietary Supplements presents peer-reviewed, objective entries that rigorously examine the most significant scientific research on basic chemical, preclinical, and clinical data. Designed for healthcare professionals, researchers, and health-conscious consumers, it presents evidence-based information on the major vitamin and mineral micronutrients, herbs, botanicals, phytochemicals, and other bioactive preparations. Supplements covered include: Vitamins, beta-carotene, niacin, and folate Omega-3 and omega-6 fatty acids, isoflavones, and quercetin Calcium, copper, iron, and phosphorus 5-hydroxytryptophan, glutamine, and L-arginine St. John's Wort, ginkgo biloba, green tea, kava, and noni Androstenedione, DHEA, and melatonin Coenzyme Q10 and S-adenosylmethionine Shiitake, maitake, reishi, and cordiceps With nearly 100 entries contributed by renowned subject-specific experts, the book serves as a scientific checkpoint for the many OTC supplements carried in today's nutritional products marketplace. Also Available OnlineThis Taylor & Francis encyclopedia is also available through online subscription, offering a variety of extra benefits for researchers, students, and librarians, including: Citation tracking and alerts Active reference linking Saved searches and marked lists HTML and PDF format options Contact Taylor and Francis for more information or to inquire about subscription options and print/online combination packages. US: (Tel) 1.888.318.2367; (E-mail) e-reference@taylorandfrancis.com International: (Tel) +44 (0) 20 7017 6062; (E-mail) online.sales@tandf.co.uk |
| tamoxifen alternatives 2022: Breast MR Imaging Christiane Kuhl, 2006 |
| tamoxifen alternatives 2022: Your Bones Lara Pizzorno, Jonathan V. Wright, 2013 You are at risk for osteoporosis. If you are a woman, you're at high risk for osteoporosis -- Why conventional medicine is not the answer for strong bones. The patent medicines prescribed to prevent osteoporosis should be your last choice for healthy bones -- What increases your risk for osteoporosis? What you don't know can give you osteoporosis ; What else increases my risk for osteoporosis ; What men don't know can increase their risk for osteoporosis ; Chances are, you are already losing bone -- How to have strong bones for life. Strong bones for life, naturally -- If I follow these recommendations, what can I expect? How soon will I see results? |
| tamoxifen alternatives 2022: Optimizing IUI Results Sunita Tandulwadkar, 2024-02-02 Intrauterine insemination (IUI), also known as artificial insemination, is a fertility treatment that uses a catheter to place washed sperm directly into the uterus. Its aim is to increase the number of sperm reaching the fallopian tubes and subsequently increase the chances of fertilisation (American Pregnancy Association). This book is a comprehensive guide to the planning and process of intrauterine insemination. Eleven sections cover basics, investigations, ultrasonography, ovulation induction protocols, ovulation trigger, techniques, luteal phase support, analysis of results, and IUI in special situations such as subfertility, endometriosis, HIV, and unexplained infertility. This second edition has been fully revised to provide the latest advances in technologies and techniques. A complete section is dedicated to recent updates in the field, covering artificial intelligence and IUI, and IUI guidelines. The book concludes with Frequently Asked Questions to assist learning and understanding. The previous edition (9788184489194) published in 2010. |
| tamoxifen alternatives 2022: Molecular Markers and Targeted Therapy for Hepatobiliary Tumors, volume I.A Yunfei Xu, Zongli Zhang, Hongda Liu , Xuesong Gu, 2024-07-26 Hepatobiliary tumor, mainly including hepatocellular carcinoma, cholangiocarcinoma and gallbladder cancer, is a group of highly aggressive malignancies. Hepatocellular carcinoma, cholangiocarcinoma and gallbladder cancer have different biological characters, histopathological traits, and treatment strategies, but have similar clinical features such as silent early symptom and extremely poor prognosis. The diagnostic, predictive or prognostic tumor biomarkers of hepatobiliary cancers are in unmet need. In contrast to the poor outcome, the treatment options to hepatobiliary cancers are very limited. It is still controversial about the effects of chemotherapy and radiotherapy of hepatobiliary cancer. FDA-approved targeted drugs are only Sorafenib and Lenvatinib for hepatocellular carcinoma, and Pemigatinib for cholangiocarcinoma. Unfortunately, these drugs are only effective for 5%-30% patients. Therefore, more attention should be called upon on investigating effective biomarkers and drug targets, stratifying high-risk patients, guiding precise treatments, and developing therapeutic strategies for hepatobiliary cancers. This Research Topic aims at discussing the current knowledge and proceedings of diagnostic, predictive and prognostic tumor biomarkers in hepatobiliary cancer, and presenting the recent advances on new drug targets and potential targeted therapies of hepatobiliary cancer. We welcome submissions of Review, Mini-Review, Clinical Trial and Original Research articles covering, but not limited to, the following topics: 1. new diagnostic/prognostic factors, biomarkers and/or risk factors in hepatobiliary tumors 2. new drug targets, and oncogenic or tumor suppressive molecular mechanism of the novel targets 3. new intervention or targeted therapy in hepatobiliary tumors 4. new findings of bioinformatics or high-throughput methods such as mass spectrometry and genome-wide association studies or which may help screen the potential biomarkers of hepatobiliary tumors 5. clinical studies such as cohort study or RCT to identify new risks or treatment therapies in hepatobiliary tumors 6. basic, pharmacological, preclinical or clinical study of potential drugs targeting hepatobiliary tumors Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic. |
| tamoxifen alternatives 2022: Each Woman’s Menopause: An Evidence Based Resource Patricia Geraghty, 2021-12-03 This book is designed to meet the needs of nurse practitioners, other advanced practice nurses, and allied health professionals working in women’s health, primary care, and other specialties. The multiple roles the clinician embraces in menopause management include that of direct caregiver, manager of therapeutics, educator, and interdisciplinary team member or leader. This book provides updated, evidence based information on the menopause transition from the late reproductive stage to post-menopause to optimize the interaction of the clinician and the individual woman in each of those roles. Women’s lived experiences of menopause and women’s concerns regarding both the menopause transition and the choice of care options are included as critical components of shared therapy decisions. The review of natural menopause physiology and the variability of menopause symptoms are inclusive of diverse women and diverse trajectories. The impact of menopause on chronic disease, sleep, weight and nutrition, mood and cognition, urogenital health and sexuality, as well as vasomotor symptoms are each developed as individual topics by experts in those fields. Evidence based management using hormonal and non-hormonal options, and life-style and other complementary interventions are discussed with the most updated advantages and disadvantages of each treatment option. Consistent with advanced practice nursing theory, the approach is whole patient focused. |
| tamoxifen alternatives 2022: Precision Medicine in Clinical Practice Mandana Hasanzad, 2022-09-30 The book provides complete information on the cornerstones of precision medicine through the omics approach. Clinical applications of genomics and precision medicine have progressed from a theoretical wish list to an impactful force in medical practice.Step-by-step descriptions are provided from basics to the future application and its benefit in clinical practice. Precision medicine aims to personalize health care by tailoring decisions and treatments to each individual in every possible way. Precision medicine includes pharmacogenomics. Essential information is provided on the role of precision medicine and pharmacogenomics in the clinical practice of cancer, cardiovascular disease, diabetes, psychiatric disease, and also the importance for healthcare professionals. This book will assist the practitioners how to integrate precision medicine and pharmacogenomics data into their clinical practice. It is hoped that physicians, pharmacists, and scientists with basic scientific knowledge of precision medicine will findthis book useful. |
Tamoxifen: Uses, Side Effects & Risks - Cleveland Clinic
Tamoxifen is a hormone therapy used to treat hormone receptor-positive breast cancer. It can greatly reduce the risk of cancer recurrence (return) and invasive cancer. Some people take …
Tamoxifen - Uses, Side Effects, and More - WebMD
Jul 21, 2024 · Overview: Tamoxifen is commonly used to treat certain types of breast cancer. It is also used to lower your risk of invasive breast cancer and keep some breast cancers from …
Tamoxifen Uses, Dosage, Side Effects - Drugs.com
Jul 29, 2024 · Tamoxifen is used to treat some types of breast cancer in men and women. Tamoxifen is also used to lower a woman's chance of developing breast cancer if she has a …
Tamoxifen - StatPearls - NCBI Bookshelf
Mar 28, 2025 · Tamoxifen is a selective estrogen receptor modulator used to treat breast cancer in various clinical settings. This drug is particularly effective for patients with estrogen …
Tamoxifen - Wikipedia
Tamoxifen, sold under the brand name Nolvadex among others, is a selective estrogen receptor modulator used to prevent breast cancer in women and men. [15] It is also being studied for …
Tamoxifen | Cancer information - Cancer Research UK
Tamoxifen is a hormone therapy drug to treat breast cancer in women and men. It is also sometimes called endocrine therapy. You pronounce tamoxifen as ta-mox-si-fen.
Tamoxifen: Side Effects, Dosage, Uses, and More - Healthline
Jun 22, 2022 · Tamoxifen oral tablet is used to treat and help prevent breast cancer. Learn about side effects, warnings, dosage, and more.
Breast Cancer Prevention: Tamoxifen and Raloxifene
Tamoxifen is used mainly to treat hormone receptor-positive breast cancer (breast cancer with cells that have estrogen and/or progesterone receptors on them). Raloxifene is used mostly to …
Tamoxifen: MedlinePlus Drug Information
Tamoxifen is used to treat breast cancer that has spread to other parts of the body in men and women. It is used to treat early breast cancer in women who have already been treated with …
Tamoxifen for Breast Cancer Treatment | Susan G. Komen®
Feb 26, 2025 · Tamoxifen (Nolvadex) is a hormone therapy (also called endocrine therapy). It’s been used for over 40 years to treat hormone-receptor positive early, locally advanced and …
Tamoxifen: Uses, Side Effects & Risks - Cleveland Clinic
Tamoxifen is a hormone therapy used to treat hormone receptor-positive breast cancer. It can greatly reduce the risk of cancer recurrence (return) and invasive cancer. Some people take …
Tamoxifen - Uses, Side Effects, and More - WebMD
Jul 21, 2024 · Overview: Tamoxifen is commonly used to treat certain types of breast cancer. It is also used to lower your risk of invasive breast cancer and keep some breast cancers from …
Tamoxifen Uses, Dosage, Side Effects - Drugs.com
Jul 29, 2024 · Tamoxifen is used to treat some types of breast cancer in men and women. Tamoxifen is also used to lower a woman's chance of developing breast cancer if she has a high …
Tamoxifen - StatPearls - NCBI Bookshelf
Mar 28, 2025 · Tamoxifen is a selective estrogen receptor modulator used to treat breast cancer in various clinical settings. This drug is particularly effective for patients with estrogen …
Tamoxifen - Wikipedia
Tamoxifen, sold under the brand name Nolvadex among others, is a selective estrogen receptor modulator used to prevent breast cancer in women and men. [15] It is also being studied for …
Tamoxifen | Cancer information - Cancer Research UK
Tamoxifen is a hormone therapy drug to treat breast cancer in women and men. It is also sometimes called endocrine therapy. You pronounce tamoxifen as ta-mox-si-fen.
Tamoxifen: Side Effects, Dosage, Uses, and More - Healthline
Jun 22, 2022 · Tamoxifen oral tablet is used to treat and help prevent breast cancer. Learn about side effects, warnings, dosage, and more.
Breast Cancer Prevention: Tamoxifen and Raloxifene
Tamoxifen is used mainly to treat hormone receptor-positive breast cancer (breast cancer with cells that have estrogen and/or progesterone receptors on them). Raloxifene is used mostly to prevent …
Tamoxifen: MedlinePlus Drug Information
Tamoxifen is used to treat breast cancer that has spread to other parts of the body in men and women. It is used to treat early breast cancer in women who have already been treated with …
Tamoxifen for Breast Cancer Treatment | Susan G. Komen®
Feb 26, 2025 · Tamoxifen (Nolvadex) is a hormone therapy (also called endocrine therapy). It’s been used for over 40 years to treat hormone-receptor positive early, locally advanced and …
